Expert in Quality of Life Research, with over 30 years of experience in designing clinical trials, creating and reviewing SAP’s, and providing international guidance in PRO analysis. Over the past 25 years, we have developed more than 50 EORTC Quality of life (QOL) measures. As the former Director of the EORTC QOL Department, I lead this department, offering specialized PRO services to over 50 large and small pharma and biotech companies.

Our bespoke concierge consultancy service is crafted to meet your specific needs, focusing primarily on QOL and patient-reported outcomes (PROs). While our services extend beyond the scope of oncology, we excels in this field, rendering us a valuable asset for any study related to cancer research. We have provided guidance to the FDA and EMA in shaping policies for QOL, Clinical Outcome Assessment and trained numerous companies on the optimal approach to securing PRO approvals from regulatory bodies. Our experience with various HTA bodies ensures a nuanced understanding of their specific requirements.We now also support international CROs that have limited experience in the PRO field.

What distinguishes us is our unparalleled experience in working with diverse measures, including an impressive publication track record spanning over 25 years in designing and implementing European Organisation for Research and Treatment of Cancer (EORTC) measures and designing thier clinical trials. Our founder, formerly responsible for creating the majority of EORTC tools, and designing all of thier trials, possesses a deep understanding and familiarity with these measures, uniquely qualifying us to assist in the design, interpretation, and publication of your studies and clinical trials. Additionally, our team excels in providing systematic reviews, ensuring comprehensive and rigorous analyses of existing literature.

As part of our comprehensive service, we offer training and education programs covering all aspects of QOL use in both clinical and real-world studies. Having collaborated with regulators such as the FDA and EMA, and contributing to policy setting with HTA bodies, we understand the value of equipping researchers with the necessary skills to effectively use the power of QOL data. By choosing our consultancy service, you gain access to our extensive knowledge and practical insights, empowering your team to excel in this vital research domain.

All our work operates internationally, USA, EU, across various disease settings, including Oncology, MS, T1D, Neurology, cardiovascular, etc. Contact us today to explore how our concierge consultancy service can enhance your research outcomes and drive scientific progress to new heights.